Gardasil vaccine

PreclinicalVaccine

JJohns Hopkins University

Gardasil vaccine is one of 70 biologic programs targeting Chronic Kidney Disease. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Chronic Kidney DiseaseActive, not recruiting

PapillomaActive, not recruiting

Chronic Kidney DiseasePreclinical

Active, not recruiting

PapillomaPreclinical

Active, not recruiting

Competition

Competitive Landscape

540 competitors in Chronic Kidney Disease

#DrugCompanyPhaseTrials

Aranesp

Amgen

Preclinical

40 2

Epogen

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Preclinical

16 3

Uloric

Takeda

Preclinical

3 4

Flomax

Epoetin Beta

5 6

Genotropin

EMD Serono

Preclinical

1 7

Verquvo

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Preclinical

1 8

Sodium Valproate

AstraZeneca

Preclinical

4 9

Tradjenta

Boehringer Ingelheim

Preclinical

1 10

Nitrostat

VViatris Specialty LLC

Preclinical

—

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Health Services1 trial

Comparing Health Services Interventions for the Prevention of HPV-related Cancer

Completed·CCHU de Reims·Phase 4·NCT02837926·63 enrolled

Immunogenicity1 trial

A Cohort Study to Assess Sustained Immunogenicity to qHPV Vaccine Among HIV-infected Girls and Boys Age 9-14 Years

Completed·KKenya Medical Research Institute··NCT01446718·179 enrolled

Papilloma1 trial

Immunogenicity to Human Papillomavirus Vaccine (Gardasil) Among IBD Patients on Immunosuppressive Therapy

Completed·—·N/A·NCT00727636·53 enrolled

HPV Vaccine1 trial

Preparedness Study - HPV Vaccine

Completed·HH. Lee Moffitt Cancer Center and Research Institute·N/A·NCT01489527·406 enrolled

Chronic Kidney Disease1 trial

Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease

Completed·JJohns Hopkins University·N/A·NCT00806676·67 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for Gardasil vaccine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Gardasil vaccine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Gardasil vaccine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Johns Hopkins University company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Vaccine[2]
Highest Phase: Preclinical[1]
Company: JJohns Hopkins University

Gardasil vaccine

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Health Services1 trial

Immunogenicity1 trial

Papilloma1 trial

HPV Vaccine1 trial

Chronic Kidney Disease1 trial

References

Drug Info

Quick Facts

Related News